DE60224449D1 - Gebrauchsfertige paracetamol injektionslösungen enthaltend propylenglykol als einziges cosolvens - Google Patents

Gebrauchsfertige paracetamol injektionslösungen enthaltend propylenglykol als einziges cosolvens

Info

Publication number
DE60224449D1
DE60224449D1 DE60224449T DE60224449T DE60224449D1 DE 60224449 D1 DE60224449 D1 DE 60224449D1 DE 60224449 T DE60224449 T DE 60224449T DE 60224449 T DE60224449 T DE 60224449T DE 60224449 D1 DE60224449 D1 DE 60224449D1
Authority
DE
Germany
Prior art keywords
ready
propylene glycol
cosolven
injection solutions
solutions contain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60224449T
Other languages
English (en)
Other versions
DE60224449T2 (de
Inventor
Thao Nguyen-Xuan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bigmar-Bioren Pharmaceuticals Saen Liquidati Ch
Original Assignee
Bioren SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioren SA filed Critical Bioren SA
Publication of DE60224449D1 publication Critical patent/DE60224449D1/de
Application granted granted Critical
Publication of DE60224449T2 publication Critical patent/DE60224449T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60224449T 2001-10-16 2002-10-15 Gebrauchsfertige paracetamol injektionslösungen enthaltend propylenglykol als einziges cosolvens Expired - Lifetime DE60224449T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI20012135 2001-10-16
IT2001MI002135A ITMI20012135A1 (it) 2001-10-16 2001-10-16 Soluzioni iniettabili pronte all'uso di paracetamolo
PCT/EP2002/011498 WO2003033026A1 (en) 2001-10-16 2002-10-15 Ready-to-use paracetamol injection solutions containing propylene glycol as the only cosolvent

Publications (2)

Publication Number Publication Date
DE60224449D1 true DE60224449D1 (de) 2008-02-14
DE60224449T2 DE60224449T2 (de) 2009-04-02

Family

ID=11448506

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60224449T Expired - Lifetime DE60224449T2 (de) 2001-10-16 2002-10-15 Gebrauchsfertige paracetamol injektionslösungen enthaltend propylenglykol als einziges cosolvens

Country Status (15)

Country Link
US (1) US8178121B2 (de)
EP (1) EP1465663B1 (de)
JP (1) JP4543679B2 (de)
CN (1) CN1274293C (de)
AT (1) ATE382369T1 (de)
AU (1) AU2002342826B2 (de)
CA (1) CA2463681C (de)
DE (1) DE60224449T2 (de)
DK (1) DK1465663T3 (de)
ES (1) ES2301685T3 (de)
IL (2) IL161390A0 (de)
IT (1) ITMI20012135A1 (de)
NZ (1) NZ532936A (de)
PT (1) PT1465663E (de)
WO (1) WO2003033026A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2851164B1 (fr) 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
FR2862872A1 (fr) * 2003-12-02 2005-06-03 Palbian Snc Composition a l'etat aqueux pour l'application perfusable d'un principe actif, notamment pharmacologique tel que le paracetamol.
EP2010166B1 (de) * 2006-04-17 2013-11-06 The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services Antiretrovirale mittel aus organischem disulfiden
US9585849B2 (en) 2006-04-17 2017-03-07 The Burlington Hc Research Group, Inc. Broad spectrum antiviral and methods of use
CA2628806C (en) * 2006-07-18 2012-08-21 Genfarma Laboratorio S.L. Injectable liquid paracetamol formulation
EP1992334A1 (de) * 2007-05-08 2008-11-19 Docpharma NV/SA Lagerfähige Formulierung eines oxidationsempfindlichen phenolhaltigen Arzneimittels, insbesondere Paracetamol, mit einer wässrigen, durch ein temperaturgeregeltes Herstellungsverfahren desoxidierten Arzneimittellösung
BRPI0816478B1 (pt) * 2007-08-30 2018-02-14 Iogen Energy Corporation Processos de fermentação para a produção de uma mistura de celulases e de hidrólise de um substrato de celulose e uso de mistura de celulases em processo de fermentação
ES2321906B1 (es) * 2008-11-28 2010-02-09 Laboratorios Normon, S.A. Composicion farmaceutica que comprende una solucion acuosa de paracetamol.
EP2243477A1 (de) 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol zur parenteralen Verabreichung
ES2389760T3 (es) 2010-04-14 2012-10-31 B. Braun Melsungen Ag Composición de acetaminofeno
ES2414557B1 (es) * 2012-01-16 2014-06-10 Novocat Farma, S.A. Composición acuosa de paracetamol para inyección
US20140303254A1 (en) * 2013-04-08 2014-10-09 InnoPharma Licensing LLC Process Of Manufacturing A Stable, Ready To Use Infusion Bag For An Oxidation Sensitive Formulation
BR102014005885B1 (pt) 2014-03-13 2021-04-13 Biotec Biológica Indústria Farmacêutica Ltda E.P.P Formulação farmacêutica líquida injetável estável de paracetamol em bolsa plástica pronta para uso
EA028075B1 (ru) * 2014-04-29 2017-10-31 Мыкола Ивановыч ГУМЕНЮК Фармацевтическая композиция
BR112017012975B1 (pt) 2014-12-20 2023-09-26 Troikaa Pharmaceuticals Limited Formulações injetáveis de paracetamol

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930000029B1 (ko) 1984-03-14 1993-01-06 제롬 꼬르비에르 N-아실 인돌류 활성성분의 용해방법
KR930011994B1 (ko) * 1991-08-16 1993-12-23 대광제약 주식회사 파라세타몰의 생체이용율을 높이는 방법 및 이 생체이용율이 높아진 파라세타몰을 함유한 제제
JP3430320B2 (ja) 1994-03-14 2003-07-28 あづま姿株式会社 衣紋掛
JP3913795B2 (ja) * 1995-09-28 2007-05-09 エスエス製薬株式会社 安定な解熱鎮痛剤配合液剤
JPH09286724A (ja) * 1996-04-19 1997-11-04 Takeda Chem Ind Ltd 経口用安定液剤
FR2751875B1 (fr) * 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
US5766622A (en) 1996-08-14 1998-06-16 The Procter & Gamble Company Inhibiting undesirable taste in oral compositions
IT1301976B1 (it) 1998-07-31 2000-07-20 Angelini Ricerche Spa Composizione farmaceutica iniettabile a base di paracetamolo
US6006659A (en) * 1998-10-13 1999-12-28 Rosenthal; Richard A. Personal pasteurization system
FR2809619B1 (fr) 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
DE10112325A1 (de) 2001-03-13 2002-10-02 Fresenius Kabi De Gmbh Lagerstabile Fertiginfusionslösungen des Paracetamols

Also Published As

Publication number Publication date
CA2463681A1 (en) 2003-04-24
DK1465663T3 (da) 2008-05-13
JP4543679B2 (ja) 2010-09-15
CN1571678A (zh) 2005-01-26
US20040247627A1 (en) 2004-12-09
CN1274293C (zh) 2006-09-13
EP1465663B1 (de) 2008-01-02
EP1465663A1 (de) 2004-10-13
US8178121B2 (en) 2012-05-15
IL161390A0 (en) 2004-09-27
IL161390A (en) 2009-06-15
AU2002342826B2 (en) 2006-09-07
JP2005505609A (ja) 2005-02-24
ITMI20012135A1 (it) 2003-04-16
CA2463681C (en) 2011-03-15
PT1465663E (pt) 2008-04-10
DE60224449T2 (de) 2009-04-02
ATE382369T1 (de) 2008-01-15
ES2301685T3 (es) 2008-07-01
WO2003033026A1 (en) 2003-04-24
NZ532936A (en) 2007-04-27

Similar Documents

Publication Publication Date Title
DE60224449D1 (de) Gebrauchsfertige paracetamol injektionslösungen enthaltend propylenglykol als einziges cosolvens
EA200201119A1 (ru) Лиганды меланокортиновых рецепторов
EA200300348A1 (ru) Спирогетероциклические нитрилы, пригодные для применения в качестве обратимо действующих ингибиторов цистеиновых протеаз
DK1478394T3 (da) Stabiliseret TNFR-Fc formulation med arginin
DK1273299T3 (da) Minoxidilinindeholdende praparater
ATE312081T1 (de) 6-phenylphenanthridine mit pde-iv hemmender wirkung
EA200100315A1 (ru) Простые тетрагидропиридовые эфиры
SG150550A1 (en) Pharmaceutical preparation containing an antibody for the egf receptor
MA27748A1 (fr) Formulation liquide injectable de paracetamol
BR0016665A (pt) Composição alvejante, e, métodos de alvejamento e de preparação de uma composição alvejante
ATE430589T1 (de) Wasserbehandlung zur kontrolle von biobewuchs mittels stabilisierter bromlösungen
EA199900693A1 (ru) Атропизомеры 3-арил-4(3h)-хиназолинонов и их использование в качестве антагонистов амра-рецепторов
DK0876140T3 (da) Forbedrede kontrastmiddelopløsninger til intravasal anvendelse
PT1200426E (pt) Tieno-3-il-sulfonilamino (tio) carbonil-triazolino (ti) onas substituidas
DE602004015725D1 (de) Stabilisierte lyophilisierte zubereitungen mit gewebefaktor-inhibitor (tfpi) oder varianten des gewebefaktor-inhibitors
ATE356810T1 (de) Polysubstituted 6-phenylphenanthridines mit pde- iv hemmender wirkung
ATE294793T1 (de) Phenantrhridin-n-oxides mit pde-iv hemmender wirkung
DE60025327D1 (de) 6-arylphenanthridine mit pde-iv hemmender wirkung
BR0001201A (pt) Composto ( poli ) tia-alcinóicos, composição cosmética, utilização de uma composição cosmética, utilização de um composto e composição farmacêutica
EE05124B1 (et) Toimeainena dotsetakseeli v?i selle hdraati sisaldava kompositsiooni kasutamine
EA200100333A1 (ru) Инсектицидная композиция
IS6654A (is) Stöðugt gabapentín með pH innan stýrðra marka
DE60020079D1 (de) Phenanthridine-n-oxide mit pde-iv hemmender wirkung
TR200101493T2 (tr) Eletriptan hidrobromid monohidrat
SE9903290D0 (sv) Novel compounds

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BIGMAR-BIOREN PHARMACEUTICALS S.A.EN LIQUIDATI, CH

R082 Change of representative

Ref document number: 1465663

Country of ref document: EP

Representative=s name: NOTARBARTOLO & GERVASI GMBH, 80336 MUENCHEN, DE